Is a complete LXRX research report available?

No complete published report is available for Lexicon Pharmaceuticals, Inc. (LXRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · USD

$1.48

-0.01 (-0.3%)· Recorded snapshot

Market cap	656.3M
Revenue (ttm)	41.5M
Net income (ttm)	-61.1M
EPS (ttm)	-$0.16
Shares out	445M
Volume	1,311,272
Beta	1.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.5M
Net income (ttm): -61.1M
EPS (ttm): -$0.16
Market cap: 656.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001062822
Company name	Lexicon Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	528872302
Earnings date	2026-11-09
Earnings time	bmo
Employees	81
Employees change	-22
Employees growth	-21.36%
Enterprise value	$524.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1995
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2000-04-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US5288723027
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2015-05-21
Last stock split type	Reverse
Market cap	$656.3M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.48
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LXRX
U.S. state	Texas
Website	https://www.lexpharma.com

Metric

Value

Amount currency

USD

CIK code

0001062822

Company name

Lexicon Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

528872302

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-22

Employees growth

-21.36%

Enterprise value

$524.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1995

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2000-04-07

Is primary listing

Yes

Is SPAC

ISIN number

US5288723027

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2015-05-21

Last stock split type

Reverse

Market cap

$656.3M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.48

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

LXRX

U.S. state

Texas

Website

https://www.lexpharma.com

Metric	Value
Earnings yield	-10.76%
EV/Sales	12.55x
FCF / EV yield	-12.49%
FCF yield	-9.97%
Forward EV/Sales	31.38x
Forward P/S	39.31x
P/B ratio	3.77x
P/S ratio	15.72x
Price / tangible book value	5.02x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-10.76%

EV/Sales

12.55x

FCF / EV yield

-12.49%

FCF yield

-9.97%

Forward EV/Sales

31.38x

Forward P/S

39.31x

P/B ratio

3.77x

P/S ratio

15.72x

Price / tangible book value

5.02x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-131.43%
EBITDA margin	-130.27%
Gross margin	86.02%
Operating margin	-131.43%
Pretax margin	-147.38%
Profit margin	-147.38%
Profit per employee	$-754,519
Revenue per employee	$511,963
ROA	-14.32%
ROA (5Y)	-35.92%
ROCE	-23.16%
ROE	-40.21%
ROE (5Y)	-105.85%
ROIC	-16.04%
SBC / revenue	30.61%

Metric

Value

EBIT margin

-131.43%

EBITDA margin

-130.27%

Gross margin

86.02%

Operating margin

-131.43%

Pretax margin

-147.38%

Profit margin

-147.38%

Profit per employee

$-754,519

Revenue per employee

$511,963

ROA

-14.32%

ROA (5Y)

-35.92%

ROCE

-23.16%

ROE

-40.21%

ROE (5Y)

-105.85%

ROIC

-16.04%

SBC / revenue

30.61%

Metric	Value
EPS growth years	2
Gross profit growth	-32.79%
Net income growth years	1
Revenue growth	-29.03%
Revenue growth (Q)	-97.6%
Revenue growth (QoQ)	-96.72%
Revenue growth 10Y	-12.65%
Revenue growth 3Y	367.06%
Revenue growth 5Y	42.35%
Revenue growth years	3

Metric

Value

EPS growth years

Gross profit growth

-32.79%

Net income growth years

Revenue growth

-29.03%

Revenue growth (Q)

-97.6%

Revenue growth (QoQ)

-96.72%

Revenue growth 10Y

-12.65%

Revenue growth 3Y

367.06%

Revenue growth 5Y

42.35%

Revenue growth years

Metric	Value
Depreciation and amortization	$481,000
EBIT	$-54.5M
EBITDA	$-54M
EPS	$-0.16
FCF per share	$-0.15
Financing cash flow	$85.3M
Free cash flow	$-65M
Free cash flow minus SBC	$-77.7M
Gross profit	$35.7M
Investing cash flow	$-29.8M
Net borrowing	$-7.3M
Net cash flow	$-9.4M
Net income	$-61.1M
Operating cash flow minus SBC	$-77.7M
Operating income	$-54.5M
Revenue	$41.5M
Stock-based compensation	$12.7M

Metric

Value

Depreciation and amortization

$481,000

EBIT

$-54.5M

EBITDA

$-54M

EPS

$-0.16

FCF per share

$-0.15

Financing cash flow

$85.3M

Free cash flow

$-65M

Free cash flow minus SBC

$-77.7M

Gross profit

$35.7M

Investing cash flow

$-29.8M

Net borrowing

$-7.3M

Net cash flow

$-9.4M

Net income

$-61.1M

Operating cash flow minus SBC

$-77.7M

Operating income

$-54.5M

Revenue

$41.5M

Stock-based compensation

$12.7M

Metric	Value
Altman Z-Score	-6.5
Book value per share	$0.39
Debt / equity	0.34
Goodwill	$44.5M
Interest coverage	-6.5
Long-term assets	$53.5M
Long-term liabilities	$60.8M
Net cash (debt)	$131.4M
Net cash / market cap	20.15%
Net cash growth	69.31%
Net debt / equity	-0.75
Piotroski F-Score	2
Property, plant and equipment	$8.6M
Shareholders' equity	$174.5M
Tangible book value	$130M
Tangible book value per share	$0.29
Total assets	$250.1M
Total cash	$190.6M
Total debt	$59.2M
Total liabilities	$75.5M
WACC	10.27%

Metric

Value

Altman Z-Score

-6.5

Book value per share

$0.39

Debt / equity

0.34

Goodwill

$44.5M

Interest coverage

-6.5

Long-term assets

$53.5M

Long-term liabilities

$60.8M

Net cash (debt)

$131.4M

Net cash / market cap

20.15%

Net cash growth

69.31%

Net debt / equity

-0.75

Piotroski F-Score

Property, plant and equipment

$8.6M

Shareholders' equity

$174.5M

Tangible book value

$130M

Tangible book value per share

$0.29

Total assets

$250.1M

Total cash

$190.6M

Total debt

$59.2M

Total liabilities

$75.5M

WACC

10.27%

Metric	Value
Asset turnover	0.17
Current assets	$196.6M
Current liabilities	$14.7M
Current ratio	13.37
Inventory turnover	8.5
Net working capital	$-7.1M
Quick ratio	13.07
Working capital	$181.9M
Working capital turnover	0.28

Metric

Value

Asset turnover

0.17

Current assets

$196.6M

Current liabilities

$14.7M

Current ratio

13.37

Inventory turnover

8.5

Net working capital

$-7.1M

Quick ratio

13.07

Working capital

$181.9M

Working capital turnover

0.28

Metric	Value
Buyback yield / dilution	-7.98%
Dividend yield	0%
Shareholder yield	-7.98%

Metric

Value

Buyback yield / dilution

-7.98%

Dividend yield

Shareholder yield

-7.98%

Metric	Value
10Y price change	-90.43%
10Y return CAGR	-20.92%
10Y total return	-90.43%
150-day SMA	$2.02
15Y price change	-83.89%
15Y return CAGR	-11.46%
15Y total return	-83.89%
1D price change	-0.34%
1M price change	-18.94%
1M total return	-18.94%
1W price change	-7.91%
1W total return	-7.91%
1Y price change	4.68%
1Y return CAGR	4.68%
1Y total return	4.68%
20-day SMA	$1.62
200-day SMA	$1.88
20Y price change	-94.72%
20Y return CAGR	-13.68%
20Y total return	-94.72%
3M price change	-34.75%
3M total return	-34.75%
3Y price change	31.08%
3Y return CAGR	9.44%
3Y total return	31.08%
50-day SMA	$1.92
50-day SMA vs 200-day SMA	50over200
52-week high	$2.68
52-week high date	2026-06-30
52-week low	$1.10
52-week low date	2026-01-30
5Y price change	-71.64%
5Y return CAGR	-22.28%
5Y total return	-71.64%
6M price change	-13.91%
6M total return	-13.91%
All-time high	$344.75
All-time high date	2000-07-21
All-time low	$0.28
All-time low date	2025-03-03
Average true range (ATR)	$0.09
Average volume	1.9M
Beta (1Y)	0.78
Beta (2Y)	1.74
Beta (5Y)	1.08
Change from 52-week high	-44.96%
Change from 52-week low	34.09%
Change from all-time high	-99.58%
Change from all-time low	413.05%
Change from open	1.03%
Day's gap	-1.35%
Dollar volume	$1.9M
High price	$1.48
Low price	$1.44
Monthly RSI	47.01
Open price	$1.46
Position in 52-week range	100%
Premarket change	2.03%
Premarket close	$1.48
Premarket price	$1.51
Previous close	$1.48
Price vs 150-day SMA	-27.79%
Price vs 20-day SMA	-10.02%
Price vs 200-day SMA	-22.69%
Price vs 50-day SMA	-24.3%
Relative volume	0.68
RSI	30.56
Sharpe ratio	0.37
Sharpe ratio (3Y)	0.58
Sharpe ratio (5Y)	0.2
Sortino ratio	0.65
Sortino ratio (3Y)	0.94
Sortino ratio (5Y)	0.36
Volume	1.3M
Weekly RSI	37.59
YTD price change	26.52%
YTD total return	26.52%

Metric

Value

10Y price change

-90.43%

10Y return CAGR

-20.92%

10Y total return

-90.43%

150-day SMA

$2.02

15Y price change

-83.89%

15Y return CAGR

-11.46%

15Y total return

-83.89%

1D price change

-0.34%

1M price change

-18.94%

1M total return

-18.94%

1W price change

-7.91%

1W total return

-7.91%

1Y price change

4.68%

1Y return CAGR

4.68%

1Y total return

4.68%

20-day SMA

$1.62

200-day SMA

$1.88

20Y price change

-94.72%

20Y return CAGR

-13.68%

20Y total return

-94.72%

3M price change

-34.75%

3M total return

-34.75%

3Y price change

31.08%

3Y return CAGR

9.44%

3Y total return

31.08%

50-day SMA

$1.92

50-day SMA vs 200-day SMA

50over200

52-week high

$2.68

52-week high date

2026-06-30

52-week low

$1.10

52-week low date

2026-01-30

5Y price change

-71.64%

5Y return CAGR

-22.28%

5Y total return

-71.64%

6M price change

-13.91%

6M total return

-13.91%

All-time high

$344.75

All-time high date

2000-07-21

All-time low

$0.28

All-time low date

2025-03-03

Average true range (ATR)

$0.09

Average volume

1.9M

Beta (1Y)

0.78

Beta (2Y)

1.74

Beta (5Y)

1.08

Change from 52-week high

-44.96%

Change from 52-week low

34.09%

Change from all-time high

-99.58%

Change from all-time low

413.05%

Change from open

1.03%

Day's gap

-1.35%

Dollar volume

$1.9M

High price

$1.48

Low price

$1.44

Monthly RSI

47.01

Open price

$1.46

Position in 52-week range

100%

Premarket change

2.03%

Premarket close

$1.48

Premarket price

$1.51

Previous close

$1.48

Price vs 150-day SMA

-27.79%

Price vs 20-day SMA

-10.02%

Price vs 200-day SMA

-22.69%

Price vs 50-day SMA

-24.3%

Relative volume

0.68

RSI

30.56

Sharpe ratio

0.37

Sharpe ratio (3Y)

0.58

Sharpe ratio (5Y)

0.2

Sortino ratio

0.65

Sortino ratio (3Y)

0.94

Sortino ratio (5Y)

0.36

Volume

1.3M

Weekly RSI

37.59

YTD price change

26.52%

YTD total return

26.52%

Metric	Value
Float	219M
Float percentage	49.22%
Shares change (QoQ)	9.35%
Shares change (YoY)	7.98%
Shares held by insiders	1.46%
Shares held by institutions	34.49%
Shares outstanding	445M
Short % of float	11.79%
Short % of shares	5.8%
Short ratio	7.6 days

Metric

Value

Float

219M

Float percentage

49.22%

Shares change (QoQ)

9.35%

Shares change (YoY)

7.98%

Shares held by insiders

1.46%

Shares held by institutions

34.49%

Shares outstanding

445M

Short % of float

11.79%

Short % of shares

5.8%

Short ratio

7.6 days

Lexicon Pharmaceuticals, Inc. (LXRX)

Price

Financial snapshot

Fair-value bridge

Latest news · LXRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LXRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LXRX

Frequently asked questions